Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37
Published December 11, 2024 · Recall initiated: October 25, 2024
Summary
FDA records drug Class II recall D-0112-2025, published December 11, 2024 and initiated October 25, 2024. Recalling firm: Lannett Company Inc.; Status: Terminated; Reported quantity: 1608 bottles; Lot: Lot: 23274856A, Exp 04/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
What to do
Voluntary: Firm initiated · Letter
Get an email if LISDEXAMFETAMINE DIMESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer
- Lannett Company Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0305274664379
- Lot
- Lot: 23274856A, Exp 04/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDA10 Irregular Pigmentation, Accelerator, Pigment Fading Activator, Only Your Rx, Nature + Science, 1 fl. oz.,December 11, 2024
- FDAOneMultivitaminic GAF-PLUS Advance 300ml, plastic bottle, Room TemperatureDecember 11, 2024
Questions about this recall
Was Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37 recalled?
Yes. FDA published recall D-0112-2025 on December 11, 2024. Reported hazard: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LISDEXAMFETAMINE DIMESYLATE. UPC: 0305274664379.